Corpus 1,284 assessed · 1,185 scored · 647 reproduced ≥75 · 173 flagged ·∅ 73.9/100

Publications 2 Datasets 392.5k Experiments 5.7k

Explore

Filters: The University of Osaka ✕ rna-seq ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses. PMID 40128415	Breast Cancer	2025	71	L1 71/100
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma. PMID 36650150	Nat Commun	2023	96	L1 96/100

IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses.

PMID 40128415 · Breast Cancer · 2025

L1 71/100

In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma.

PMID 36650150 · Nat Commun · 2023

L1 96/100